Playback speed
10 seconds
ESMO 2024 Insights: EMBARK Study Post-Hoc Analysis By Age - Enzalutamide +/- Leuprolide in Patients With High-Risk Biochemically Recurrent Prostate Cancer
By
2024 ESMO Annual Meeting Insights Hub
FEATURING
Neal Shore
By
2024 ESMO Annual Meeting Insights Hub
FEATURING
Neal Shore
0 views
September 27, 2024
Login to view comments.
Click here to Login